Medtech Insight - News And Expert Analysis For Medtech Decision Makers since 1975

Commercial


LSX Nordic 2024: Strategics Offer Tips On Landing A Partnership Or Acquisition

At this year’s LSX Nordic conference, experts from Baxter, Philips and Novo Nordisk described key attributes they look for when selecting companies for partnerships or acquisitions and provided advice to founders on how and when to start positioning their start-ups for such opportunities.

Digital Technologies


Medtech Crystal-Gazing: Investors Emphasize Need To Center Medtech In Patient Continuum

Medtech Crystal-Gazing: Investors Emphasize Need To Center Medtech In Patient Continuum

 

Industry experts believe the future of medtech will be centered around patients and their data. To thrive, medtech companies must integrate themselves more organically in the patient continuum and adopt more of a Big Tech mindset in order to meet users' evolving expectations.

Marabio Systems Raised $19M In Series A For Blood Test To Detect Autism

Marabio Systems Raised $19M In Series A For Blood Test To Detect Autism

 
• By 

Marabio Systems says the new funding will help accelerate efforts to bring a blood test to market in 2025 that will accurately determine if a mother is a carrier of antibodies that cause MARA, a subtype of autism that believe to cause more severe behavior.

Some Perspectives From Medtech Industry Leaders Heard At Octane OC

Some Perspectives From Medtech Industry Leaders Heard At Octane OC

 
• By 

The Octane Medical Innovation Forum brought together industry experts, entrepreneurs and investors to discuss a range of topics. Medtech Insight was on the ground to bring some memorable perspectives from industry leaders.

FDA Publishes Updated ‘Roadmap’ For Advancing Women’s Health

FDA Publishes Updated ‘Roadmap’ For Advancing Women’s Health

 

The US FDA’s Office of Women’s Health provides a research roadmap to address health concerns specific to women. The FDA recently updated the roadmap, outlining areas in which further research is needed.

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.  

Inbrain Has Sights On Parkinson’s Following First-In-Human Test Of Graphene-Based Implant

Inbrain Has Sights On Parkinson’s Following First-In-Human Test Of Graphene-Based Implant

 
• By 

Spain-based Inbrain Neuroelectronics plans first-in-human study to show safety of its graphene-based technology in direct contact with human brain while also developing a second interface for treating Parkinson’s disease.

Research Finds AI Stethoscopes Detect Heart Failure Signs

Research Finds AI Stethoscopes Detect Heart Failure Signs

 

The results from a trio of studies show that AI-powered digital stethoscopes are effective at identifying patients at elevated risk of experiencing heart attacks and other major cardiac adverse events, according to Eko Health, whose technology was used to screen the participants in the studies.

Empowering Primary Care Physicians With Digital Biomarkers For Early Alzheimer’s Detection

Empowering Primary Care Physicians With Digital Biomarkers For Early Alzheimer’s Detection

 
• By 

Altoida CEO Mark Jones has high hopes that the company’s digital assessment tool will be approved by the FDA to be used along with blood biomarker testing by primary care doctors to help predict Alzheimer’s disease before patients show symptoms.